In this article by Outsourcing Pharma, Quotient Sciences CEO Thierry Van Nieuwenhove shared insights on how the company is adapting to new FDA regulations.
Thierry also discusses how the company is expanding its Translational Pharmaceutics® platforms into new therapeutic areas like mRNA.
Continue reading the full article on Outsourcing Pharma.